Risk Factors of Pre-eclampsia/eclampsia and Its Adverse Outcomes in Low- and Middle-income Countries: a WHO Secondary Analysis
Overview
Affiliations
Background: Pre-eclampsia has an immense adverse impact on maternal and perinatal health especially in low- and middle-income settings. We aimed to estimate the associations between pre-eclampsia/eclampsia and its risk factors, and adverse maternal and perinatal outcomes.
Methods: We performed a secondary analysis of the WHO Global Survey on Maternal and Perinatal Health. The survey was a multi-country, facility-based cross-sectional study. A global sample consisting of 24 countries from three regions and 373 health facilities was obtained via a stratified multi-stage cluster sampling design. Maternal and offspring data were extracted from records using standardized questionnaires. Multi-level logistic regression modelling was conducted with random effects at the individual, facility and country levels.
Results: Data for 276,388 mothers and their infants was analysed. The prevalence of pre-eclampsia/eclampsia in the study population was 10,754 (4%). At the individual level, sociodemographic characteristics of maternal age ≥30 years and low educational attainment were significantly associated with higher risk of pre-eclampsia/eclampsia. As for clinical and obstetric variables, high body mass index (BMI), nulliparity (AOR: 2.04; 95%CI 1.92-2.16), absence of antenatal care (AOR: 1.41; 95%CI 1.26-1.57), chronic hypertension (AOR: 7.75; 95%CI 6.77-8.87), gestational diabetes (AOR: 2.00; 95%CI 1.63-2.45), cardiac or renal disease (AOR: 2.38; 95%CI 1.86-3.05), pyelonephritis or urinary tract infection (AOR: 1.13; 95%CI 1.03-1.24) and severe anemia (AOR: 2.98; 95%CI 2.47-3.61) were found to be significant risk factors, while having >8 visits of antenatal care was protective (AOR: 0.90; 95%CI 0.83-0.98). Pre-eclampsia/eclampsia was found to be a significant risk factor for maternal death, perinatal death, preterm birth and low birthweight.
Conclusion: Chronic hypertension, obesity and severe anemia were the highest risk factors of preeclampsia/eclampsia. Implementation of effective interventions prioritizing risk factors, provision of quality health services during pre-pregnancy and during pregnancy for joint efforts in the areas of maternal health are recommended.
Zielinska J, Darmochwal-Kolarz D Med Sci Monit. 2025; 31:e945628.
PMID: 40007059 PMC: 11871747. DOI: 10.12659/MSM.945628.
African-Colombian woman with preeclampsia and high-risk APOL1 genotype: A case report.
Duran C, Gutierrez-Medina J, Trivino Arias J, Sandoval-Calle L, Barbosa M, Useche E Medicine (Baltimore). 2024; 103(44):e40284.
PMID: 39496047 PMC: 11537606. DOI: 10.1097/MD.0000000000040284.
Karpova N, Dmitrenko O, Nurbekov M Int J Mol Sci. 2024; 25(20).
PMID: 39456889 PMC: 11508172. DOI: 10.3390/ijms252011108.
Sk M Health Care Sci. 2024; 2(1):45-59.
PMID: 38939742 PMC: 11080819. DOI: 10.1002/hcs2.28.
Al-Nuaimi A Medicine (Baltimore). 2024; 103(25):e38557.
PMID: 38905404 PMC: 11192010. DOI: 10.1097/MD.0000000000038557.